Skip to main content

Table 1 The scaffold modifications used in this study

From: Argon plasma surface modification promotes the therapeutic angiogenesis and tissue formation of tissue-engineered scaffolds in vivo by adipose-derived stem cells

Scaffold Group Number

Scaffold Type

Scaffolds Modification Technique

Abbreviation

1

Control Scaffolds

Polyurethane nanocomposite scaffolds without modification

PU

2

Scaffold modified with ADSCs

Polyurethane nanocomposite scaffolds modified with 1 x 106 cells per scaffold. ADSCs seeded on the scaffold for 24 hours prior to implantation.

ADSC

3

Scaffold modified with PRP

Scaffold modified with PRP at a concentration of 20.2 x 104/ml with a 30 minute incubation time prior to implantation.

PRP

4

Scaffolds modified with plasma surface modification

Scaffold modified with argon plasma surface modification for 5 minutes immediately prior to implantation.

PM

5

Scaffolds modified with plasma surface modification + ADSC

Scaffolds modified as per group 2 and 4.

PM + ADSC

6

Scaffolds modified with plasma surface modification + PRP.

Scaffolds modified as per group 3 and 4.

PM + PRP

7

Scaffolds modified with ADSC + PRP.

Scaffold modified with 2 + 3.

ADSC + PRP

8

Scaffolds modified with plasma surface modification + PRP + ADSC

Scaffolds modified as per group 2 and 3 and 4.

PM + PRP + ADSC